Copyright
©The Author(s) 2019.
World J Clin Cases. Dec 26, 2019; 7(24): 4234-4244
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4234
Published online Dec 26, 2019. doi: 10.12998/wjcc.v7.i24.4234
Table 2 Patient characteristics in multiple myeloma cohorts, n (%)
| Characteristics | All patients (n = 67) | IL-32 ≥ 856.4 pg/mL (n = 38) | IL-32 < 856.4 pg/mL (n = 29) | P value |
| IL-32 (pg/mL), median (Range) | 798.2 (232.1-4214) | 1354.4 (856.4-4214) | 426.7 (232.1-856.4) | < 0.001 |
| MRD negative | 23 (35.9) | 9 (23.7) | 14 (48.3) | < 0.001 |
| MRD positive | 44 (65.7) | 29 (76.3) | 15 (51.7) |
- Citation: Wang G, Ning FY, Wang JH, Yan HM, Kong HW, Zhang YT, Shen Q. Expression of interleukin-32 in bone marrow of patients with myeloma and its prognostic significance. World J Clin Cases 2019; 7(24): 4234-4244
- URL: https://www.wjgnet.com/2307-8960/full/v7/i24/4234.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i24.4234